Tony Quinones, CEO of Bright Path Laboratories, discusses the latest on the omicron variant and Covid vaccines with Bryan Curtis and Paul Allen on Bloomberg Daybreak Asia.
Tony Quinones on the Latest on Covid Vaccines – Bloomberg
read more
Media
Life Sciences Supply Chain Disruptions Likely to Persist through 2022
Supply chain disruption will be with biopharmaceutical companies for the foreseeable future, according to the recent CFO survey, Supply Chain Resilience, by BDO. A separate report by Catalent, Allogeneic and Autologous Cell Therapies Report 2022, agrees, saying,...
Bright Path Labs expands Board of Directors – Marc Fasteau
Vice-Chairman of the Coalition for a Prosperous America. Bright Path Labs has appointed Mr. Marc Fasteau as an independent director. Tony Quinones, CEO of BPL, stated, "We are extraordinarily honored and pleased that Mr. Fasteau has elected to join our board as an...
How will Quartic’s partnership with Bright Path Labs expand its presence in the life sciences?
Rajiv Anand, Founder and CEO, Quartic.ai Bright Path Labs has a technology that brings speed to the commercialization of API production. Continuous manufacturing is a big need in the pharmaceutical sector and Bright Path lab's technology accelerates that process. In...
Bright Path Laboratories selects TrackWise Digital QMS
Sparta Systems, provider of Quality Management System (QMS) platforms TrackWise and TrackWise Digital, has announced that Bright Path Laboratories, a leader in continuous-flow reactor technology, has selected TrackWise Digital as their QMS of the future. Bright Path...
Quartic.ai and Bright Path Labs partner on AI-powered continuous manufacturing
Quartic.ai, a manufacturing AI and IIoT platform supplier, and Bright Path Laboratories, a provider of continuous flow reactor technologies, have signed an agreement to develop an AI-powered continuous manufacturing platform for active pharmaceutical ingredients...
One America Network Reports, Fixing our Dependence on China for Drug Manufacturing
Bright Path Laboratories Develops New Way to Produce Active Pharmaceutical Ingredients
Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT)...
Contract Pharma Reports, Bright Path Labs Accepted into FDA’s Emerging Technology Program
Bright Path Laboratories, Inc. (BPL), a provider of continuous flow reactor technology, was accepted into the FDA's Emerging Technology Program, paving the way for the company to provide its low-cost and scalable technology to the domestic API manufacturing sector....